Overcoming Pharmaceutical Formulation Challenges - Fuji Chemical Webinars

7 October 2020 & 13 October 2020 – both 12:00 PM EST, 9:00 AM PST

Using Speciality Excipients from Fuji Chemical Industries to Develop High Quality Medicine.
Join Fuji in their upcoming Webinar on how to solve your formulation related challenges using Fuji Chemical’s specialty excipient.

Key Discussions:

7 October 2020 – 12:00 PM EST, 9:00 AM PST:

Neusilin: Multi-functional excipient for pharmaceutical applications, Neusilin® can improve tablet ability and stability through its superior flowability, compressibility and moisture protection capabilities.
Fujicalin: Non-abrasive porous DCPA for the versatile applications such as for probiotic tablet compression, black spots prevention in tablet compression and cushioning excipient for MUPS tablet by utilizing its unique plasticity and cushioning property.

13 October 2020 – 12:00 PM EST, 9:00 AM PST:

F-Melt: Co-processed excipients are generally required to meet the stringent dissolution times and mouthfeel needed for ODT’s. An independent study by GSK and UCL compares commercially available coprocessed excipients for ODT’s and demonstrates the case for F-Melt®.
Fujisil: Next generation highly porous silica for oil adsorption, improvement of tableting process and solubility enhancement application.

Speaker:

Dr. Mark Plunkett

Technical Market Manager – Fuji Chemical Industries

Mark’s passion and focus is surface chemistry. He holds a B.S. in Chemistry from Sydney University and a PhD in Surface Chemistry from The Royal Institute of Technology in Stockholm. He has held visiting scientist positions at Bristol University, Unilever Corporation and Max Planck Institute for Polymer Research. He currently resides in Sweden and manages the European market for Fuji Chemical Industries